[1]屈云,李小会,刘争辉,等.黄菟益肾颗粒治疗特发性膜性肾病临床疗效及对尿足细胞糖萼蛋白的影响[J].中国中医药信息杂志,2019,26(7):26-29.[doi:10.3969/j.issn.1005-5304.2019.07.007]
 QU Yun,LI Xiaohui,LIU Zhenghui,et al.Clinical Efficacy of Huangtu Yishen Granules on Idiopathic Membranous Nephropathy Patients and Its Effect on Urinary Podocalyxin[J].zhongguo zhongyiyao xinxi zazhi,2019,26(7):26-29.[doi:10.3969/j.issn.1005-5304.2019.07.007]
点击复制

黄菟益肾颗粒治疗特发性膜性肾病临床疗效及对尿足细胞糖萼蛋白的影响

参考文献/References:

[1] GLASSOCK R J. The pathogenesis of membranous nephropathy:evolution and revolution[J]. Curr Opin Nephrol Hypertens,2012, 21(3):235-242.
[2] ZHU P, ZHOU F D, WANG S X, et al. Increasing frequency of idiopathic membranous nephropathy in primary glomerular disease:a 10-year renal biopsy study from a single Chinese nephrology centre[J]. Nephrology (Carlton),2015,20(8):560-566.
[3] 章友康,李英.膜性肾病的诊断与治疗[J].中华肾病研究电子杂志, 2013,2(1):5-10.
[4] GLASSOCK R J. Diagnosis and natural course of membranous nephropathy[J]. Semin Nephrol,2003,23(4):324-332.
[5] HLADUNEWICH M, TROYANOV S, CALAFATI J, et al. The natural history of the non-nephrotic membranous nephropathy patient[J]. Clin J Am Soc Nephrol,2009,4(9):1417-1422.
[6] 杜雨茂.杜雨茂肾脏病临床经验集粹[M].北京:中国中医药出版社, 2013:1.
[7] 杜雨茂.原发性难治性肾病综合征的辨证论治思路与方法[J].陕西中医学院学报,2010,33(4):1-5.
[8] 董正华,赵天才.杜雨茂学术思想与临证经验集锦[M].西安:陕西科学技术出版社,2015:3.
[9] 李小会,雷根平,潘冬辉.名老中医杜雨茂教授运用经方辨治慢性肾脏病经验采撷[J].中国中西医结合肾病杂志,2012,13(2):101-102.
[10] 邹万忠,王海燕.肾活检病理学[M].北京:北京大学医学出版社, 2014:79-83.
[11] 黎磊石,刘志红.中国肾脏病学(上册)[M].北京:人民军医出版社,2008:64-65.
[12] 王海燕.KDIGO肾小球肾炎临床实践指南[M].北京:人民卫生出版社, 2013:105-145.
[13] AKHTAR M, AL M H. Molecular basis of proteinuria[J]. Adv Anat Pathol,2004,11(6):304-309.
[14] JEFFERSON J A, SHANKLAND S J, PICHLER R H. Proteinuria in diabetic kidney disease:a mechanistic viewpoint[J]. Kidney Int, 2008,74(1):22-36.
[15] GLASSOCK R J. The pathogenesis of idiopathic membranous nephropathy:a 50-year odyssey[J]. Am J Kidney Dis,2010,56(1):157-167.
[16] DROSSOPOULOU G I, TSOTAKOS N E, TSILIBARY E C. Impaired transcription factor interplay in addition to advanced glycation end products suppress podocalyxin expression in high glucose- treated human podocytes[J]. Am J Physiol Renal Physiol,2009, 297(3):F594-603.
[17] PETERMANN A, FLOEGE J. Podocyte damage resulting in podocyturia:a potential diagnostic marker to assess glomerular disease activity[J]. Nephron Clin Pract,2007,106(2):c61-66.
[18] HARA M, YANAGIHERE T, KIHARA I, et al. Apical cell membranes are shed into urine from injured podocytes:a novel phenomenon of podocyte injure[J]. J Am Soe Nephrol,2005,16(2):408-416.
[19] YE H, BAI X, GAO H, et al. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy[J]. J Diabetes Complications,2014,28(1):96-100.
[20] 刘静,殷俊,陈晓岚,等.特发性膜性肾病中抗M型磷脂酶A2受体抗体、血管生成素样蛋白-4及可溶性尿激酶型纤溶酶原激活物受体的临床意义[J].南通大学学报:医学版,2017,37(3):196-202.
[21] 庄克生,杨洪庆,李连朝,等.自拟芪藤通络饮经验方治疗特发性膜性肾病50例[J].环球中医药,2018,11(1):142-145.

相似文献/References:

[1]王涛,指导:檀金川.檀金川论治特发性膜性肾病经验[J].中国中医药信息杂志,2017,24(10):105.[doi:10.3969/j.issn.1005-5304.2017.10.026]
 WANG Tao,Instructor: TAN Jin-chuan.Experience of TAN Jin-chuan in Treatment of Idiopathic Membranous Nephropathy[J].zhongguo zhongyiyao xinxi zazhi,2017,24(7):105.[doi:10.3969/j.issn.1005-5304.2017.10.026]

备注/Memo

基金项目:陕西省科技厅项目(2011JM4020、2019JM-107);咸阳市科技局项目(2018k02-98);陕西省中医药管理局伤寒学与经方辨治疑难病重点研究室(2018年);国家中医药管理局第四批全国中医(临床、基础)优秀人才研修项目(2017年)

更新日期/Last Update:

2019-06-20